Publikationen, an denen er mitarbeitet Ángel Rodríguez Villodres (11)

2023

  1. Role of blaTEM and OmpC in the piperacillin-tazobactam resistance evolution by E. coli in patients with complicated intra-abdominal infection

    Journal of Infection, Vol. 87, Núm. 3, pp. 220-229

2022

  1. Ultrasensitive and rapid identification of ESRI developer- and piperacillin/tazobactam-resistant Escherichia coli by the MALDIpiptaz test

    Emerging Microbes and Infections, Vol. 11, Núm. 1, pp. 2034-2044

2021

  1. Impact of the COVID-19 Pandemic on Survival in the Patients With the Intra-Abdominal Infections

    Frontiers in Medicine, Vol. 8

  2. Semirapid detection of piperacillin/tazobactam resistance and extended-spectrum resistance to b-lactams/b-lactamase inhibitors in clinical isolates of escherichia coli

    Microbiology Spectrum, Vol. 9, Núm. 2

2020

  1. Antibacterial activity of colloidal silver against gram-negative and gram-positive bacteria

    Antibiotics, Vol. 9, Núm. 1

  2. Extended-spectrum resistance to β-lactams/β-lactamase inhibitors (ESRI) evolved from low-level resistant Escherichia coli

    Journal of Antimicrobial Chemotherapy, Vol. 75, Núm. 1, pp. 77-85

  3. In vitro effect of ceftazidime-avibactam pressure on ceftazidime-avibactam resistance in KPC-producing Klebsiella pneumoniae clinical isolates

    Biosaia: Revista de los másteres de Biotecnología Sanitaria y Biotecnología Ambiental, Industrial y Alimentaria, Núm. 9

  4. Repositioning rafoxanide to treat Gram-negative bacilli infections

    Journal of Antimicrobial Chemotherapy, Vol. 75, Núm. 7, pp. 1895-1905

2019

  1. Antibacterial activity of colloidal silver against Gram-negative and Gram-positive bacteria.

    Biosaia: Revista de los másteres de Biotecnología Sanitaria y Biotecnología Ambiental, Industrial y Alimentaria, Núm. 8

  2. Phylogeny, resistome, and virulome of escherichia coli causing biliary tract infections

    Journal of Clinical Medicine, Vol. 8, Núm. 12

2018

  1. Heteroresistance to piperacillin-tazobactam in clinical isolates of Escherichia coli sequence type 131

    Antimicrobial Agents and Chemotherapy